Nanotechnology in therapeutics : a focus on nanoparticles as a drug delivery system Review
暂无分享,去创建一个
Weihong Tan | Ting Fu | Zilong Zhao | Tao Chen | W. Tan | Zilong Zhao | Ting Fu | S. Bamrungsap | Lin Wang | Lin Wang | Tao Chen | Chunmei Li | Chunmei Li | W. Tan | Suwussa Bamrungsap
[1] He Lian,et al. Dual targeting folate-conjugated hyaluronic acid polymeric micelles for paclitaxel delivery. , 2011, International journal of pharmaceutics.
[2] Chung-Yuan Mou,et al. The effect of surface charge on the uptake and biological function of mesoporous silica nanoparticles in 3T3-L1 cells and human mesenchymal stem cells. , 2007, Biomaterials.
[3] J. Pedraz,et al. Micro and nano drug delivery systems in cancer therapyArticle , 2005 .
[4] A. R. Kulkarni,et al. Biodegradable polymeric nanoparticles as drug delivery devices. , 2001, Journal of controlled release : official journal of the Controlled Release Society.
[5] Ulrik B Nielsen,et al. Anti-HER2 immunoliposomes: enhanced efficacy attributable to targeted delivery. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.
[6] C. Hawker,et al. Preparation of polymers with controlled molecular architecture. A new convergent approach to dendritic macromolecules , 1990 .
[7] Deng-Fwu Hwang,et al. In vitro cytotoxicitiy of silica nanoparticles at high concentrations strongly depends on the metabolic activity type of the cell line. , 2007, Environmental science & technology.
[8] A. Prokop,et al. Nanovehicular intracellular delivery systems. , 2008, Journal of pharmaceutical sciences.
[9] R. Satchi‐Fainaro,et al. Polymer therapeutics for cancer : Current status and future challenges , 2006 .
[10] S. P. Vyas,et al. Potential of polysaccharide anchored liposomes in drug delivery, targeting and immunization. , 2001, Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques.
[11] Thommey P. Thomas,et al. Synthesis and in vitro testing of J591 antibody-dendrimer conjugates for targeted prostate cancer therapy. , 2004, Bioconjugate chemistry.
[12] S. Nie,et al. Therapeutic Nanoparticles for Drug Delivery in Cancer Types of Nanoparticles Used as Drug Delivery Systems , 2022 .
[13] P. Sabbatini,et al. Phase II study of CT-2103 in patients with recurrent epithelial ovarian, fallopian tube, or primary peritoneal carcinoma. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[14] C. Brazel,et al. Synthesis and characterization of grafted thermosensitive hydrogels for heating activated controlled release. , 2007, International journal of pharmaceutics.
[15] Samir Mitragotri,et al. Particle shape: a new design parameter for micro- and nanoscale drug delivery carriers. , 2007, Journal of controlled release : official journal of the Controlled Release Society.
[16] Lisbeth Illum,et al. Long circulating microparticulate drug carriers , 1995 .
[17] Victor S-Y Lin,et al. Mesoporous silica nanoparticles for intracellular delivery of membrane-impermeable proteins. , 2007, Journal of the American Chemical Society.
[18] V. Torchilin. Recent advances with liposomes as pharmaceutical carriers , 2005, Nature Reviews Drug Discovery.
[19] Richard B Greenwald,et al. Effective drug delivery by PEGylated drug conjugates. , 2003, Advanced drug delivery reviews.
[20] G Blume,et al. Liposomes for the sustained drug release in vivo. , 1990, Biochimica et biophysica acta.
[21] Hans P. Merkle,et al. Phagocytosis and Phagosomal Fate of Surface-Modified Microparticles in Dendritic Cells and Macrophages , 2003, Pharmaceutical Research.
[22] P. Midgley,et al. Uptake of C60 by human monocyte macrophages, its localization and implications for toxicity: studied by high resolution electron microscopy and electron tomography. , 2006, Acta biomaterialia.
[23] S. Sahoo,et al. Nanotech approaches to drug delivery and imaging. , 2003, Drug discovery today.
[24] R K Jain,et al. Barriers to drug delivery in solid tumors. , 1994, Scientific American.
[25] S. Pramod,et al. Carbon Nanotubes in Pharmaceutical Nanotechnology: An introduction to Future Drug Delivery System , 2013 .
[26] Sung Ju Cho,et al. Quantum dot-induced cell death involves Fas upregulation and lipid peroxidation in human neuroblastoma cells , 2007, Journal of nanobiotechnology.
[27] E. Zubarev,et al. Paclitaxel-functionalized gold nanoparticles. , 2007, Journal of the American Chemical Society.
[28] Samuel Zalipsky,et al. In vivo fate of folate-targeted polyethylene-glycol liposomes in tumor-bearing mice. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.
[29] Y. Barenholz,et al. Systemic administration of doxorubicin-containing liposomes in cancer patients: a phase I study. , 1989, European journal of cancer & clinical oncology.
[30] Umesh Gupta,et al. A review of in vitro-in vivo investigations on dendrimers: the novel nanoscopic drug carriers. , 2006, Nanomedicine : nanotechnology, biology, and medicine.
[31] Jianjun Cheng,et al. Drug-Initiated, Controlled Ring-Opening Polymerization for the Synthesis of Polymer-Drug Conjugates. , 2012, Macromolecules.
[32] M. Yatvin,et al. pH-sensitive liposomes: possible clinical implications. , 1980, Science.
[33] Weihong Tan,et al. DNA aptamer–micelle as an efficient detection/delivery vehicle toward cancer cells , 2009, Proceedings of the National Academy of Sciences.
[34] Elaine Merisko-Liversidge,et al. Nanosizing: a formulation approach for poorly-water-soluble compounds. , 2003, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[35] S. Nguyen,et al. Polymer-caged lipsomes: a pH-responsive delivery system with high stability. , 2007, Journal of the American Chemical Society.
[36] D Gan,et al. Tunable swelling kinetics in core--shell hydrogel nanoparticles. , 2001, Journal of the American Chemical Society.
[37] E. Oberdörster. Manufactured Nanomaterials (Fullerenes, C60) Induce Oxidative Stress in the Brain of Juvenile Largemouth Bass , 2004, Environmental health perspectives.
[38] Fabio Cerignoli,et al. Quantum dot-doped silica nanoparticles as probes for targeting of T-lymphocytes , 2007, International journal of nanomedicine.
[39] N. B. Graham,et al. Nanogels and microgels: The new polymeric materials playground , 1998 .
[40] L. Recht,et al. A randomized controlled trial comparing intrathecal sustained-release cytarabine (DepoCyt) to intrathecal methotrexate in patients with neoplastic meningitis from solid tumors. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.
[41] D. Ding,et al. Nanospheres-incorporated implantable hydrogel as a trans-tissue drug delivery system. , 2011, ACS nano.
[42] Rainer H Müller,et al. Nanocrystal technology, drug delivery and clinical applications , 2008, International journal of nanomedicine.
[43] Indrajit Roy,et al. Organically modified silica nanoparticles with covalently incorporated photosensitizer for photodynamic therapy of cancer. , 2007, Nano letters.
[44] Norio Tada,et al. A novel magnetic crystal-lipid nanostructure for magnetically guided in vivo gene delivery. , 2009, Nature nanotechnology.
[45] M. Bergeron,et al. Treatment of Visceral Leishmaniasis with Sterically Stabilized Liposomes Containing Camptothecin , 2001, Antimicrobial Agents and Chemotherapy.
[46] Kenneth K. Chan,et al. Phase I and pharmacologie study of liposomal daunorubicin (DaunoXome) , 2004, Investigational New Drugs.
[47] F. Szoka,et al. Chemical approaches to triggerable lipid vesicles for drug and gene delivery. , 2003, Accounts of chemical research.
[48] W. Oyen,et al. Factors affecting the accelerated blood clearance of polyethylene glycol-liposomes upon repeated injection. , 2001, The Journal of pharmacology and experimental therapeutics.
[49] F. Torti,et al. The use of cardiac biopsy to demonstrate reduced cardiotoxicity in AIDS Kaposi's sarcoma patients treated with pegylated liposomal doxorubicin. , 1998, Annals of oncology : official journal of the European Society for Medical Oncology.
[50] Wolfgang J Parak,et al. Laser-induced release of encapsulated materials inside living cells. , 2006, Angewandte Chemie.
[51] B. Říhová,et al. Clinical implications of N-(2-hydroxypropyl)methacrylamide copolymers. , 2003, Current pharmaceutical biotechnology.
[52] S M Moghimi,et al. Long-circulating and target-specific nanoparticles: theory to practice. , 2001, Pharmacological reviews.
[53] D. Discher,et al. Shape effects of filaments versus spherical particles in flow and drug delivery. , 2007, Nature nanotechnology.
[54] G. Hughes,et al. Nanostructure-mediated drug delivery. , 2005, Disease-a-month : DM.
[55] Zonghuan Lu,et al. Magnetic switch of permeability for polyelectrolyte microcapsules embedded with Co@Au nanoparticles. , 2005, Langmuir : the ACS journal of surfaces and colloids.
[56] M. Dobrovolskaia,et al. Immunological properties of engineered nanomaterials , 2007, Nature Nanotechnology.
[57] B. Badie,et al. Internalization of MWCNTs by microglia: Possible application in immunotherapy of brain tumors , 2007, NeuroImage.
[58] H. Ringsdorf,et al. Polymeric Antitumor Agents on a Molecular and on a Cellular Level , 1981 .
[59] M. Radomski,et al. Nanoparticles: pharmacological and toxicological significance , 2007, British journal of pharmacology.
[60] Mauro Ferrari,et al. Nanomedicine—Challenge and Perspectives , 2009 .
[61] A. Krueger. New Carbon Materials: Biological Applications of Functionalized Nanodiamond Materials , 2008 .
[62] Yao Sun,et al. Mesoscopic simulations on the aggregation behavior of pH-responsive polymeric micelles for drug delivery. , 2011, Journal of colloid and interface science.
[63] Tim Liedl,et al. Cytotoxicity of colloidal CdSe and CdSe/ZnS nanoparticles. , 2005, Nano letters.
[64] Ruth Duncan,et al. Polymer conjugates as anticancer nanomedicines , 2006, Nature Reviews Cancer.
[65] M. Keating,et al. Clinical pharmacology of polyethylene glycol-L-asparaginase. , 1986, Drug metabolism and disposition: the biological fate of chemicals.
[66] S. Manna,et al. Single-Walled Carbon Nanotube Induces Oxidative Stress and Activates Nuclear Transcription Factor-κB in Human Keratinocytes , 2005 .
[67] O. Rosen,et al. Pegylated asparaginase in combination with high‐dose methotrexate for consolidation in adult acute lymphoblastic leukaemia in first remission: a pilot study , 2003, British journal of haematology.
[68] Y. Barenholz,et al. Transmembrane ammonium sulfate gradients in liposomes produce efficient and stable entrapment of amphipathic weak bases. , 1993, Biochimica et biophysica acta.
[69] Shuming Nie,et al. Nanotechnology in cancer therapeutics: bioconjugated nanoparticles for drug delivery , 2006, Molecular Cancer Therapeutics.
[70] A. D'emanuele,et al. In vitro evaluation of dendrimer prodrugs for oral drug delivery. , 2007, International journal of pharmaceutics.
[71] Vincent M Rotello,et al. Light-regulated release of DNA and its delivery to nuclei by means of photolabile gold nanoparticles. , 2006, Angewandte Chemie.
[72] E. Rivera. Current status of liposomal anthracycline therapy in metastatic breast cancer. , 2003, Clinical breast cancer.
[73] W. Zauner,et al. In vitro uptake of polystyrene microspheres: effect of particle size, cell line and cell density. , 2001, Journal of controlled release : official journal of the Controlled Release Society.
[74] F. Gao,et al. Effects of antisense-myc-conjugated single-walled carbon nanotubes on HL-60 cells. , 2007, Journal of nanoscience and nanotechnology.
[75] Donald A Tomalia,et al. Dendrimers in biomedical applications--reflections on the field. , 2005, Advanced drug delivery reviews.
[76] N. Shibata,et al. Liquid filled nanoparticles as a drug delivery tool for protein therapeutics. , 2005, Biomaterials.
[77] R. Zhuo,et al. Reduction-responsive polymeric micelles for anticancer drug delivery. , 2011, Journal of controlled release : official journal of the Controlled Release Society.
[78] Xianglong Hu,et al. Mixed polymeric micelles as multifunctional scaffold for combined magnetic resonance imaging contrast enhancement and targeted chemotherapeutic drug delivery , 2012 .
[79] H. Tajmir-Riahi,et al. Interaction of taxol with human serum albumin. , 2000, Biochimica et biophysica acta.
[80] J. Schellens,et al. Phase I clinical and pharmacokinetic study of PNU166945, a novel water-soluble polymer-conjugated prodrug of paclitaxel , 2001, Anti-cancer drugs.
[81] Z. Tökés,et al. In vitro and in vivo studies with adriamycin liposomes. , 1979, Biochemical and biophysical research communications.
[82] Robert Langer,et al. Impact of nanotechnology on drug delivery. , 2009, ACS nano.
[83] Warren C W Chan,et al. Elucidating the mechanism of cellular uptake and removal of protein-coated gold nanoparticles of different sizes and shapes. , 2007, Nano letters.
[84] Yanyu Xiao,et al. Octreotide-modified and pH-triggering polymeric micelles loaded with doxorubicin for tumor targeting delivery. , 2012, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[85] Jayanth Panyam,et al. Biodegradable nanoparticles for drug and gene delivery to cells and tissue. , 2003, Advanced drug delivery reviews.
[86] Marc D. Porter,et al. Alkanethiolate Gold Cluster Molecules with Core Diameters from 1.5 to 5.2 nm: Core and Monolayer Properties as a Function of Core Size , 1998 .
[87] Samir Mitragotri,et al. Role of target geometry in phagocytosis. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[88] Rona Chandrawati,et al. A microreactor with thousands of subcompartments: enzyme-loaded liposomes within polymer capsules. , 2009, Angewandte Chemie.
[89] H. Ghandehari,et al. Extravasation of Poly(amidoamine) (pamam) Dendrimers Across Microvascular Network Endothelium , 2004, Pharmaceutical Research.
[90] Zhi Zhu,et al. Photoresponsive DNA-cross-linked hydrogels for controllable release and cancer therapy. , 2011, Langmuir : the ACS journal of surfaces and colloids.
[91] H. Ringsdorf. Structure and properties of pharmacologically active polymers , 1975 .
[92] Scott J Hollister,et al. Delivery and protection of adenoviruses using biocompatible hydrogels for localized gene therapy. , 2004, Molecular therapy : the journal of the American Society of Gene Therapy.
[93] D. Mcilroy,et al. Differential cytotoxicity exhibited by silica nanowires and nanoparticles , 2008 .
[94] Jon Dobson,et al. Magnetic micro- and nano-particle-based targeting for drug and gene delivery. , 2006, Nanomedicine.
[95] Guilin Wang,et al. Recent developments in nanoparticle-based drug delivery and targeting systems with emphasis on protein-based nanoparticles. , 2008, Expert opinion on drug delivery.
[96] S. Groshen,et al. Pegylated liposomal doxorubicin (doxil): reduced clinical cardiotoxicity in patients reaching or exceeding cumulative doses of 500 mg/m2. , 2000, Annals of oncology : official journal of the European Society for Medical Oncology.
[97] P. Gupta,et al. Hydrogels: from controlled release to pH-responsive drug delivery. , 2002, Drug discovery today.
[98] Andreas M. Nyström,et al. Linear-Dendritic Polymeric Amphiphiles as Carriers of Doxorubicin-In Vitro Evaluation of Biocompatibility and Drug Delivery , 2012 .
[99] D. S. Lee,et al. Synthesis and evaluation of biotin-conjugated pH-responsive polymeric micelles as drug carriers. , 2012, International journal of pharmaceutics.
[100] W. Gradishar,et al. Albumin-bound paclitaxel: a next-generation taxane , 2006, Expert opinion on pharmacotherapy.
[101] C. Chen,et al. Preparation and properties of thermoreversible hydrogels based on methoxy poly(ethylene glycol)-grafted chitosan nanoparticles for drug delivery systems , 2011 .
[102] J. Reddy,et al. Folate-targeted chemotherapy. , 2004, Advanced drug delivery reviews.
[103] Hassan S. Bazzi,et al. Differences in subcellular distribution and toxicity of green and red emitting CdTe quantum dots , 2005, Journal of Molecular Medicine.
[104] Warren C W Chan,et al. Nanoparticle-mediated cellular response is size-dependent. , 2008, Nature nanotechnology.
[105] Indrajit Roy,et al. New method for delivering a hydrophobic drug for photodynamic therapy using pure nanocrystal form of the drug. , 2007, Molecular pharmaceutics.
[106] Tae-You Kim,et al. Phase I and Pharmacokinetic Study of Genexol-PM, a Cremophor-Free, Polymeric Micelle-Formulated Paclitaxel, in Patients with Advanced Malignancies , 2004, Clinical Cancer Research.
[107] S. Croft,et al. Liposomal amphotericin B in drug-resistant visceral leishmaniasis , 1991, The Lancet.
[108] Rebecca Richards-Kortum,et al. Optical molecular imaging agents for cancer diagnostics and therapeutics. , 2006, Nanomedicine.
[109] M. Bally,et al. The liposomal formulation of doxorubicin. , 2005, Methods in enzymology.
[110] Hua Ai,et al. Multifunctional polymeric micelles as cancer-targeted, MRI-ultrasensitive drug delivery systems. , 2006, Nano letters.
[111] F. M. Gama,et al. Development of a hybrid dextrin hydrogel encapsulating dextrin nanogel as protein delivery system. , 2012, Biomacromolecules.
[112] Shiladitya Sengupta,et al. Temporal targeting of tumour cells and neovasculature with a nanoscale delivery system , 2005, Nature.
[113] W. E. Billups,et al. Functionalization density dependence of single-walled carbon nanotubes cytotoxicity in vitro. , 2006, Toxicology letters.
[114] M. Prato,et al. Functionalized carbon nanotubes are non-cytotoxic and preserve the functionality of primary immune cells. , 2006, Nano letters.
[115] Francis C Szoka,et al. Designing dendrimers for biological applications , 2005, Nature Biotechnology.
[116] M. Grinstaff,et al. Hydrogels as intracellular depots for drug delivery. , 2012, Molecular pharmaceutics.
[117] Zahi A. Fayad,et al. Perspectives and opportunities for nanomedicine in the management of atherosclerosis , 2011, Nature Reviews Drug Discovery.
[118] H. Maeda,et al. A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. , 1986, Cancer research.
[119] R. Langer,et al. Nanomedicine: developing smarter therapeutic and diagnostic modalities. , 2006, Advanced drug delivery reviews.
[120] J. Zhang,et al. Development and characterization of a novel Cremophor EL free liposome-based paclitaxel (LEP-ETU) formulation. , 2005, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[121] J. Singer,et al. Synthesis and in Vivo Antitumor Activity of Poly(l-glutamic acid) Conjugates of 20(S)-Camptothecin , 2003 .
[122] A. Gabizon,et al. Sterically stabilized liposomes: improvements in pharmacokinetics and antitumor therapeutic efficacy. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[123] Hung-Ting Chen,et al. Synthesis and functionalization of a mesoporous silica nanoparticle based on the sol-gel process and applications in controlled release. , 2007, Accounts of chemical research.
[124] Juan L. Vivero-Escoto,et al. Mesoporous silica nanoparticles as controlled release drug delivery and gene transfection carriers. , 2008, Advanced drug delivery reviews.
[125] Takuro Niidome,et al. PEG-modified gold nanorods with a stealth character for in vivo applications. , 2006, Journal of controlled release : official journal of the Controlled Release Society.
[126] Swarnlata Saraf,et al. Nanocarriers: promising vehicle for bioactive drugs. , 2006, Biological & pharmaceutical bulletin.
[127] J. Baker,et al. Targeting the efficacy of a dendrimer-based nanotherapeutic in heterogeneous xenograft tumors in vivo , 2010, Anti-cancer drugs.
[128] Christopher G Thanos,et al. The pinpoint promise of nanoparticle-based drug delivery and molecular diagnosis. , 2006, Biomolecular engineering.
[129] P. Baron,et al. Exposure to Carbon Nanotube Material: Assessment of Nanotube Cytotoxicity using Human Keratinocyte Cells , 2003, Journal of toxicology and environmental health. Part A.
[130] M. Prato,et al. Carbon nanotubes as nanomedicines: from toxicology to pharmacology. , 2006, Advanced drug delivery reviews.
[131] V. Rotello,et al. Glutathione-mediated delivery and release using monolayer protected nanoparticle carriers. , 2006, Journal of the American Chemical Society.
[132] Mark H Schoenfisch,et al. Water-soluble nitric oxide-releasing gold nanoparticles. , 2007, Langmuir : the ACS journal of surfaces and colloids.
[133] M J Hawkins,et al. Abraxane, a novel Cremophor-free, albumin-bound particle form of paclitaxel for the treatment of advanced non-small-cell lung cancer. , 2006, Annals of oncology : official journal of the European Society for Medical Oncology.
[134] M. Grinstaff,et al. Therapeutic and diagnostic applications of dendrimers for cancer treatment. , 2008, Advanced drug delivery reviews.
[135] Kazunori Kataoka,et al. Current state, achievements, and future prospects of polymeric micelles as nanocarriers for drug and gene delivery. , 2006, Pharmacology & therapeutics.
[136] J. F. Stoddart,et al. Mesostructured Silica Supports for Functional Materials and Molecular Machines , 2007 .
[137] M Sugisaka,et al. Nanotechnology on duty in medical applications. , 2005, Current pharmaceutical biotechnology.
[138] Ana B. Descalzo,et al. The supramolecular chemistry of organic-inorganic hybrid materials. , 2006, Angewandte Chemie.
[139] J. James,et al. A Review of Carbon Nanotube Toxicity and Assessment of Potential Occupational and Environmental Health Risks , 2006, Critical reviews in toxicology.
[140] T. Xia,et al. Understanding biophysicochemical interactions at the nano-bio interface. , 2009, Nature materials.
[141] B. R. Steele,et al. New drug delivery nanosystem combining liposomal and dendrimeric technology (liposomal locked-in dendrimers) for cancer therapy. , 2010, Journal of pharmaceutical sciences.
[142] Yan Xiao,et al. Self-assembly of pH-sensitive mixed micelles based on linear and star copolymers for drug delivery. , 2011, Journal of colloid and interface science.
[143] K. Ulbrich,et al. Biodegradable star HPMA polymer-drug conjugates: Biodegradability, distribution and anti-tumor efficacy. , 2011, Journal of controlled release : official journal of the Controlled Release Society.
[144] E. Ruoslahti,et al. Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model. , 1998, Science.
[145] L. Hegedũs,et al. High affinity binding of paclitaxel to human serum albumin. , 2001, European journal of biochemistry.
[146] H. Ringsdorf,et al. Molecular Architecture and Function of Polymeric Oriented Systems: Models for the Study of Organization, Surface Recognition, and Dynamics of Biomembranes , 1988 .
[147] R. J. Lee,et al. Targeted drug delivery via the folate receptor. , 2000, Advanced drug delivery reviews.
[148] J E Kipp,et al. The role of solid nanoparticle technology in the parenteral delivery of poorly water-soluble drugs. , 2004, International journal of pharmaceutics.
[149] R. Boulieu,et al. Effect of polyethylene glycol-modified adenosine deaminase (PEG-ADA) therapy in two ADA-deficient children: measurement of erythrocyte deoxyadenosine triphosphate as a useful tool. , 1991, Advances in experimental medicine and biology.
[150] Volker Wagner,et al. The emerging nanomedicine landscape , 2006, Nature Biotechnology.
[151] S. Al-suwayeh,et al. Treatment of experimental osteomyelitis by liposomal antibiotics. , 2004, The Journal of antimicrobial chemotherapy.
[152] H. Dureja,et al. Nanoparticle technology for the delivery of poorly water-soluble drugs , 2006 .
[153] U. Schubert,et al. Poly(ethylene glycol) in drug delivery: pros and cons as well as potential alternatives. , 2010, Angewandte Chemie.
[154] Jianzhong Wu,et al. Phase behavior of thermally responsive microgel colloids. , 2003, Physical review letters.
[155] R. Barbucci,et al. A novel strategy for engineering hydrogels with ferromagnetic nanoparticles as crosslinkers of the polymer chains. Potential applications as a targeted drug delivery system , 2011 .
[156] Neil Desai,et al. Phase I and pharmacokinetics trial of ABI-007, a novel nanoparticle formulation of paclitaxel in patients with advanced nonhematologic malignancies. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[157] Xiaojun Cao,et al. A NEW CONVERGENT APPROACH TO DENDRITIC MACROMOLECULES , 2002 .
[158] Mehrdad Hamidi,et al. Hydrogel nanoparticles in drug delivery. , 2008, Advanced drug delivery reviews.
[159] Shuming Nie,et al. Bioconjugated quantum dots for in vivo molecular and cellular imaging. , 2008, Advanced drug delivery reviews.
[160] S. Slack,et al. Particle diameter influences adhesion under flow. , 2001, Biophysical journal.
[161] Xiaoling Zhang,et al. Near-infrared light-responsive core-shell nanogels for targeted drug delivery. , 2011, ACS nano.
[162] H. Ohshima,et al. Dependence of the phagocytic uptake of polystyrene microspheres by differentiated HL60 upon the size and surface properties of the microspheres , 2002 .
[163] Patrick Soon-Shiong,et al. Phase I and pharmacokinetic study of ABI-007, a Cremophor-free, protein-stabilized, nanoparticle formulation of paclitaxel. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.
[164] W. D. de Jong,et al. Drug delivery and nanoparticles: Applications and hazards , 2008, International journal of nanomedicine.
[165] A. D'emanuele,et al. Crossing cellular barriers using dendrimer nanotechnologies. , 2006, Current opinion in pharmacology.
[166] G. Levi,et al. Size, diffusibility and transfection performance of linear PEI/DNA complexes in the mouse central nervous system , 1998, Gene Therapy.
[167] J. James,et al. Pulmonary toxicity of single-wall carbon nanotubes in mice 7 and 90 days after intratracheal instillation. , 2003, Toxicological sciences : an official journal of the Society of Toxicology.
[168] J. Pinto,et al. Synthesis of Biodegradable Hydrogel Nanoparticles for Bioapplications Using Inverse Miniemulsion RAFT Polymerization , 2011 .
[169] Andre G. Skirtach,et al. Stimuli-sensitive nanotechnology for drug delivery , 2009 .
[170] Chung-Yuan Mou,et al. Size effect on cell uptake in well-suspended, uniform mesoporous silica nanoparticles. , 2009, Small.
[171] L. Murray,et al. Phase I clinical and pharmacokinetic study of PK1 [N-(2-hydroxypropyl)methacrylamide copolymer doxorubicin]: first member of a new class of chemotherapeutic agents-drug-polymer conjugates. Cancer Research Campaign Phase I/II Committee. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.
[172] Zhuang Liu,et al. Drug delivery with carbon nanotubes for in vivo cancer treatment. , 2008, Cancer research.
[173] V. Mohanraj,et al. Nanoparticles - A Review , 2007 .
[174] L. Forró,et al. Cellular toxicity of carbon-based nanomaterials. , 2006, Nano letters.
[175] Eric Pridgen,et al. Factors Affecting the Clearance and Biodistribution of Polymeric Nanoparticles , 2008, Molecular pharmaceutics.
[176] H. Pelicano,et al. Glycolysis inhibition for anticancer treatment , 2006, Oncogene.
[177] A. Kabanov,et al. Anthracycline antibiotics non-covalently incorporated into the block copolymer micelles: in vivo evaluation of anti-cancer activity. , 1996, British Journal of Cancer.
[178] Baowei Fei,et al. Highly efficient drug delivery with gold nanoparticle vectors for in vivo photodynamic therapy of cancer. , 2008, Journal of the American Chemical Society.
[179] Arezou A Ghazani,et al. Determining the size and shape dependence of gold nanoparticle uptake into mammalian cells. , 2006, Nano letters.
[180] L. Thrall. Study links TiO2 nanoparticles with potential for brain-cell damage. , 2006, Environmental science & technology.
[181] P. Glue,et al. A dose-ranging study of pegylated interferon alfa-2b and ribavirin in chronic hepatitis C. The Hepatitis C Intervention Therapy Group. , 2000, Hepatology.
[182] C. Murphy,et al. Gold nanoparticles are taken up by human cells but do not cause acute cytotoxicity. , 2005, Small.
[183] P. Chu,et al. Magnetite-loaded fluorine-containing polymeric micelles for magnetic resonance imaging and drug delivery. , 2012, Biomaterials.
[184] Naveed Ahmad,et al. Synthesis and characterization of thermo- and pH-responsive bacterial cellulose/acrylic acid hydrogels for drug delivery , 2012 .
[185] Samir Mitragotri,et al. Designer Biomaterials for Nanomedicine , 2009 .
[186] H. Shmeeda,et al. Pros and Cons of the Liposome Platform in Cancer Drug Targeting , 2006, Journal of liposome research.
[187] S. Manna,et al. Single-walled carbon nanotube induces oxidative stress and activates nuclear transcription factor-kappaB in human keratinocytes. , 2005, Nano letters.
[188] D. Mitchison,et al. The early bactericidal activity of a low-clearance liposomal amikacin in pulmonary tuberculosis. , 2001, The Journal of antimicrobial chemotherapy.
[189] G. Oberdörster,et al. Nanotoxicology: An Emerging Discipline Evolving from Studies of Ultrafine Particles , 2005, Environmental health perspectives.
[190] T. Okano,et al. Development of the polymer micelle carrier system for doxorubicin. , 2001, Journal of controlled release : official journal of the Controlled Release Society.
[191] Samir K. Gupta,et al. A Dose‐Ranging Study of Pegylated Interferon Alfa‐2b and Ribavirin in Chronic Hepatitis C , 2000 .
[192] J. Adler-Moore,et al. AmBisome targeting to fungal infections. , 1994, Bone marrow transplantation.
[193] Stephanie E. A. Gratton,et al. The effect of particle design on cellular internalization pathways , 2008, Proceedings of the National Academy of Sciences.
[194] Chong Cheng,et al. pH-Sensitive brush polymer-drug conjugates by ring-opening metathesis copolymerization. , 2011, Chemical communications.
[195] S. Cryan,et al. Carrier-based strategies for targeting protein and peptide drugs to the lungs , 2005, The AAPS Journal.
[196] Sanjiv S Gambhir,et al. A pilot toxicology study of single-walled carbon nanotubes in a small sample of mice. , 2008, Nature nanotechnology.